Regulation 63 The Medicines (Products for Human Use) (Fees) Regulations 2013
Subject to paragraphs (2) to (4), the Medicines (Products for Human Use) (Fees) Regulations 2013 M1 (“the 2013 Regulations”) are revoked.
The savings introduced by regulation 59(2) to (4) and 60(2) and (3) of the 2013 Regulations shall continue to apply as if those paragraphs of those regulations had not been revoked.
The 2013 Regulations shall continue to apply as if they had not been revoked in relation to—
capital fees payable under the 2013 Regulations in respect of any application or inspection made before the date on which these Regulations come into force; and
any periodic fee payable under the 2013 Regulations in relation to a fee period ending before the date on which these Regulations come into force.
The revocation of the 2013 Regulations shall not affect any proceedings under those Regulations for the recovery of any fees due as debts to the Crown and for the purposes of those proceedings, the 2013 Regulations shall continue to apply as if they had not been revoked.
Annotations
Marginal citations
- M1